Journal article icon

Journal article

Interferons in relapsing remitting multiple sclerosis: a systematic review.

Abstract:

BACKGROUND: Recombinant interferons have been approved by many national regulatory agencies for treatment of relapsing remitting multiple sclerosis, but widespread discussion continues about their true effectiveness, benefits, side-effects, and costs. METHODS: With the Cochrane Collaboration methodology, we reviewed all published, randomised, placebo-controlled trials of recombinant interferons undertaken in patients with relapsing remitting multiple sclerosis between 1993 and 2002. Our prim...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Human Genetics Wt Centre
Role:
Author
Expand authors...
Journal:
Lancet
Volume:
361
Issue:
9357
Pages:
545-552
Publication date:
2003-02-01
DOI:
EISSN:
1474-547X
ISSN:
0140-6736
Source identifiers:
32316
Language:
English
Keywords:
Pubs id:
pubs:32316
UUID:
uuid:67ddfce1-800c-4298-bba0-493c8fa86ace
Local pid:
pubs:32316
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP